Optimise combination therapy from the
beginning by adding Rybelsus® for additional benefits5,6
beginning by adding Rybelsus® for additional benefits5,6
PwDs with evolving CV risk
HbA1c – 8.7%
BMI: 28 kg/m2
Comorbidities:
Dyslipidemia, Chronic
Kidney Disease,
Hypertension
Dyslipidemia, Chronic
Kidney Disease,
Hypertension
Medication:
Metformin, ARBs,
Statins & SGLT2is
Metformin, ARBs,
Statins & SGLT2is
I need a diabetes
treatment plan
to help me
holistically manage
diabetes, CKD
and CV risk factors
treatment plan
to help me
holistically manage
diabetes, CKD
and CV risk factors
Mohan, 47
Not a real patient. The images of person depicted are for illustration purposes only.
Not a real case profile, depicted profile is for hypothetical purposes only
Abbreviation: CV: Cardiovascular , CKD: Chronic Kidney Disease, SGLT2i: Sodium-glucose cotransporter-2 inhibitor, ARBs: Angiotensin receptor blockers,BMI: Body mass Index, HbA1c: glycated haemoglobin
Not a real case profile, depicted profile is for hypothetical purposes only
Abbreviation: CV: Cardiovascular , CKD: Chronic Kidney Disease, SGLT2i: Sodium-glucose cotransporter-2 inhibitor, ARBs: Angiotensin receptor blockers,BMI: Body mass Index, HbA1c: glycated haemoglobin